Manufacturer record

MODI ANTIBIOTICS Plot No-28 G.I.D.C. Estate Odhav Ahmedabad 382415: regulatory record

Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories

2 batches manufactured by MODI ANTIBIOTICS Plot No-28 G.I.D.C. Estate Odhav Ahmedabad 382415 (Gujarat) were declared Not of Standard Quality between July 2026 and July 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.

Records by type

2 records linked to MODI ANTIBIOTICS Plot No-28 G.I.D.C. Estate Odhav Ahmedabad 382415 in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.

0Banned or prohibited
0Recalled or suspended
2Failed a lab test
0Regulatory notice
Primary government sourceTier 1: government primary source

CDSCO drug alerts: Not of Standard Quality and spurious drugs

CDSCO · CDSCO monthly NSQ alerts, Jul 2026 to Jul 2026

View original document

Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.

2
NSQ batches since 2026
1
Products affected
Labelling
Most common failure
Jul 2026
Latest alert

Flagged batches per year

2026 · 2

All flagged batches

Product Batch Reason declared NSQ Tested by Alert
ASPIRIN TABLET IP 75MG 240968Mfg 2024-09 · Exp 2027-08 l]five (5) intact strips often (10) tablets each were received for analysis. When the strips were opened for analysis and observed in normal daylight conditions with unaided eyes it was observed that, each pocket of the strip contains off whte,circular tablets with shiny needle shape crystals all over the surface. The tablets are very brittle in nature. 2. The content of aspirin in the sample is less (i.e.0.32% oof the labelled amount) than the i.p.limits.Labelling FDAL, MumbaiState lab Jul 2026
ASPIRIN TABLET IP 75MG 250168Mfg 2025-01 · Exp 2027-12 1. five (5) intact strips of ten (10) tablets each were received for analysis. When the strips were opened for analysis and observed in normal daylight conditions with unaided eyes it was observed that, each pocket of the strip contains off whte,circular tablets with shiny needle shape crystals all over the surface. The tablets are very brittle in nature. 2 The co tent of aspirin in the sample is less (i.e.0.32% oof the labelled amount) than the i.p.limits.Labelling FDAL, MumbaiState lab Jul 2026

Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.